B-CELL DEPLETING AGENTS, LIKE ANTI-CD20 ANTIBODIES OR FRAGMENTS THEREOF FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME

摘要

The present invention relates to an anti-CD20 antibody or a CD20-binding antibody fragment thereof for the treatment of chronic fatigue syndrome and myalgic encephalomyelitis. In particular, the present invention relates to the use of anti-CD20 monoclonal antibodies or fragments thereof which are preferably humanized for the treatment of the chronic fatigue syndrome/myalgic encephalomyelitis in a subject afflicted with said disease.